Literature DB >> 8798754

Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9.

Z Y Wang1, Q Q Qiu, W Seufert, T Taguchi, J R Testa, S A Whitmore, D F Callen, D Welsh, T Shenk, T F Deuel.   

Abstract

We report a novel human gene whose product specifically associates with the negative regulatory domain of the Wilms' tumor gene product (WT1) in a yeast two-hybrid screen and with WT1 in immunoprecipitation and glutathione S-transferase (GST) capture assays. The gene encodes a 17-kDa protein that has 56% amino acid sequence identity with yeast ubiquitin-conjugating enzyme (yUBC) 9, a protein required for cell cycle progression in yeast, and significant identity with other subfamilies of ubiquitin-conjugating enzymes. The human gene fully complements yeast that have a temperature-sensitive yUBC9 gene mutation to fully restore normal growth, indicating that we have cloned a functionally conserved human (h) homolog of yUBC9. Transcripts of hUBC9 of 4.4 kilobases (kb), 2.8 kb, and 1.3 kb were found in all human tissues tested. A single copy of the hUBC9 gene was found and localized to human chromosome 16p13.3. We conclude that hUBC9 retains striking structural and functional conservation with yUBC9 and suggest a possible link of the ubiquitin/proteosome proteolytic pathway and the WT1 transcriptional repressor system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798754     DOI: 10.1074/jbc.271.40.24811

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins.

Authors:  T Yasugi; M Vidal; H Sakai; P M Howley; J D Benson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b.

Authors:  H Hofmann; S Flöss; T Stamminger
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization.

Authors:  M Kiechle; M Hinrichs; A Jacobsen; J Lüttges; J Pfisterer; F Kommoss; N Arnold
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  HtrA2, taming the oncogenic activities of WT1.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

5.  Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.

Authors:  Andru Tomoiu; Annie Gravel; Robert M Tanguay; Louis Flamand
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.

Authors:  Y Shi; M Zou; N R Farid; M C Paterson
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

7.  Chromatin dynamics is correlated with replication timing.

Authors:  Artem Pliss; Kishore Malyavantham; Sambit Bhattacharya; Michael Zeitz; Ronald Berezney
Journal:  Chromosoma       Date:  2009-03-19       Impact factor: 4.316

8.  Identification and characterization of proteins that selectively interact with the LHR mRNA binding protein (LRBP) in rat ovaries.

Authors:  Lei Wang; Thippeswamy Gulappa; K M J Menon
Journal:  Biochim Biophys Acta       Date:  2010-02-16

Review 9.  Starting and stopping SUMOylation. What regulates the regulator?

Authors:  Felicity Z Watts
Journal:  Chromosoma       Date:  2013-06-28       Impact factor: 4.316

Review 10.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.